Table 3

Characteristics of patients aged 25–84 years in the CPRD study cohort stratified by gender with a 10-year follow-up

CharacteristicsN (%) of menN (%) of women
Patients14 175 (0.48)15 141 (0.52)
Total person-years55 60664 856
CVD event461 (0.03)321 (0.02)
Median age (IQR)58 (49–68)61 (52–71)
Median total cholesterol in mmol/L (IQR)5.3 (4.6–6.0)5.5 (4.8–6.3)
Median HDL cholesterol in mmol/L (IQR)1.3 (1.1–1.5)1.5 (1.3–1.8)
Median total cholesterol/HDL ratio (IQR)4.2 (3.4–5.0)3.6 (2.9–4.4)
Median systolic blood pressure in mmol/L (IQR)140 (128–150)140 (126–150)
Median body mass index in kg/m2 (IQR)*26.3 (23.3–30.0)26.4 (22.5–31.1)
Body mass index missing12 554 (0.89)13 339 (0.88)
Median AST/ALT ratio (IQR)0.8 (0.7–1.1)1.0 (0.8–1.3)
On blood pressure treatment3070 (0.22)3559 (0.24)
Smoking3222 (0.23)3066 (0.20)
Diabetes2678 (0.19)2305 (0.15)
Chronic kidney disease124 (0.009)84 (0.006)
Atrial fibrillation386 (0.03)315 (0.02)
Rheumatoid arthritis118 (0.008)296 (0.02)
Family history of premature CHD <60 years719 (0.05)771 (0.05)
Ethnicity*
 Caucasian5522 (0.39)6493 (0.43)
 Non-Caucasian1368 (0.10)1382 (0.09)
 Missing7285 (0.51)7266 (0.48)
Townsend quintiles
 1st—least deprived2739 (0.19)2499 (0.17)
 2nd2085 (0.15)2046 (0.14)
 3rd1679 (0.12)1875 (0.12)
 4th1622 (0.11)1837 (0.12)
 5th—most deprived940 (0.06)1149 (0.08)
 Missing5120 (0.36)5735 (0.38)
  • *Variable contains missing values.

  • Values are number and proportions unless otherwise stated.

  • ALT, alanine transaminase; AST, aspartate transaminase; CVD, cardiovascular disease; CHD, coronary heart disease; CRPD, Clinical Practice Research Datalink; HDL, high-density lipoprotein.